The extraordinary general meeting of Marksans Pharma will be held on 10 September 2008 to offer, issue and allot upto 84,00,241 equity shares of Re 1 each fully paid at a premium of Rs 19.12 per equity share aggregating to Rs 16,89,87,000 in the share capital of the company to Barnacle LLC on preferential allotment basis.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment